Mostrando 10 resultados de: 20
Filtros aplicados
Publisher
American Journal of Therapeutics(9)
Current Pharmaceutical Design(4)
Revista Latinoamericana de Hipertension(3)
American journal of therapeutics(1)
Archivos Venezolanos de Farmacologia y Terapeutica(1)
Área temáticas
Enfermedades(15)
Fisiología humana(8)
Salud y seguridad personal(5)
Medicina y salud(2)
Bioquímica(1)
Área de conocimiento
Diabetes(4)
Enfermedad cardiovascular(4)
Farmacología(4)
Bioquímica(3)
Fisiología(3)
Cigarette smoking and cardiovascular disease
ReviewAbstract: Cigarette smoking is considered a risk factor for many diseases especially for cardiovascular diseasPalabras claves:Cardiovascular disease, risk factor, smokingAutores:Aguirre M.A., Aparicio D., Bustamante M., Canelón R., Finol F., Luis Xavier Enríquez Acosta, Urdaneta A., Valmore Bermúdez, Velasco M.Fuentes:scopusAn elevated level of physical activity is associated with normal lipoprotein(a) levels in individuals from Maracaibo, Venezuela
ArticleAbstract: Coronary artery disease is the main cause of death worldwide. Lipoprotein(a) [Lp(a)], is an independPalabras claves:Cardiovascular Risk, Lifestyle, lipoprotein(a), Physical activityAutores:Acosta L., Añez-Ramos R., Aparicio D., Arráiz N., Cano R.A., Cano-Ponce C., Colmenares C., Faria J., Finol F., Mengual-Moreno E., Peñaranda L., Pineda C., Rodriguez D., Rojas E.R., Rojas-Quintero J., Sanchez W., Sorell L.T., Toledo A.C., Urribarí J., Valmore Bermúdez, Velasco M.Fuentes:scopusAnti-aging effect of metformin: A molecular and therapeutical perspective
ReviewAbstract: Aging is a time-dependent inevitable process, in which cellular homeostasis is affected, which has aPalabras claves:ageing, Anti-ageing drugs, Geronto-protective properties, Metformin, Type 2 Diabetes mellitusAutores:Cano-Ponce C., D’marco L., Galbán N., Gomez Y., González M.C., Herazo Y., Morillo V., Nava M., Rojas M., Rojas-Quintero J., Torres W., Valmore Bermúdez, Velasco M.Fuentes:scopusApproach to a successful selection of antihypertensive drugs for the patient with atherosclerosis
ArticleAbstract: Coronary heart disease has become a medical and public health issue associated with multiple risk faPalabras claves:ACE inhibitors, atherosclerosis, Coronary heart disease, Hypertension, myocardial infarctionAutores:Rojas E.R., Valmore Bermúdez, Velasco M.Fuentes:scopusExploring phytotherapeutic alternatives for obesity, insulin resistance and diabetes mellitus
ReviewAbstract: At present, the pathologic spectrum of obesity-insulin resistance (IR)-diabetes mellitus (DM) repre-Palabras claves:Cardiovascular disease, diabetes mellitus, Insulin Resistance, Medicinal herbs, obesity, PhytotherapyAutores:Cano-Ponce C., Chávez-Castillo M., Durán P., González M.C., Marquina M., Nuñez V., Ortega A., Pírela D., Rojas M., Rojas-Quintero J., Valmore Bermúdez, Velasco M.Fuentes:scopusEffect of drugs interacting with the dopaminergic receptors on glucose levels and insulin release in healthy and type 2 diabetic subjects
ArticleAbstract: Dopamine agonists play an important role in the regulation of the central nervous-cardiovascular, rePalabras claves:dopamine, Dopaminergic agonists, Dopaminergic receptors, Hypertension, Insulin, Type 2 Diabetes mellitusAutores:Bolívar H., Cano R.A., Contreras F., Foullioux C., Lares M., Leal E.M., Maroun C., Pacheco B., Valmore Bermúdez, Velasco M.Fuentes:scopusEffects of metoclopramide and metoclopramide/dopamine on blood pressure and insulin release in normotensive, hypertensive, and type 2 diabetic subjects
ArticleAbstract: The objective is to determine cardiovascular and insulin release effects under metoclopramide (MTC)Palabras claves:dopamine, Dopamine receptors, Hypertension, Insulin release, Metoclopramide, Type 2 DiabetesAutores:Bolívar H., Cano R.A., Contreras F., Fouillioux C., González M.C., Hernández-Hernandez R., Lares M., Valmore Bermúdez, Velasco M.Fuentes:scopusDirect renin inhibitors as antihypertensive agents
ReviewAbstract: Hypertension, a serious disease affecting almost a billion people (25% of adults) worldwide, is a maPalabras claves:Aliskiren, angiotensin II, Coronary heart disease, Hypertension, ReninAutores:Israili Z.H., Valmore Bermúdez, Velasco M.Fuentes:scopusNovel mutations identification in exon 4 of LDLR gene in patients with moderate hypercholesterolemia in a venezuelan population
ArticleAbstract: Familial hypercholesterolemia (FH) is an autosomal dominant disease characterized by increase in lowPalabras claves:Coronary artery disease, Familial hypercholesterolemia, Frameshift mutations, LDL-receptor, PCR-SSCPAutores:Arráiz N., Borjas L., Carem Prieto, Mujica E., Reyes F., Reyna-Villasmil N., Rondón N., Solís E., Valmore Bermúdez, Velasco M.Fuentes:googlescopusPPAR-γ agonists and their role in type 2 diabetes mellitus management
ReviewAbstract: Type 2 diabetes mellitus and obesity are the most frequent endocrine-metabolic diseases in the worldPalabras claves:diabetes mellitus, Insulin Resistance, PPARI, ThiazolidenedionesAutores:Arráiz N., Finol F., Parra M.G., Parra N., Peñaranda L., Pérez A., Rojas-Quintero J., Valmore Bermúdez, Velasco M., Vílchez D.Fuentes:scopus